Annual EBITDA
-$8.05 M
+$3.68 M+31.38%
June 30, 2024
Summary
- As of February 8, 2025, ANEB annual EBITDA is -$8.05 million, with the most recent change of +$3.68 million (+31.38%) on June 30, 2024.
- During the last 3 years, ANEB annual EBITDA has risen by +$22.19 million (+73.38%).
- ANEB annual EBITDA is now -17.85% below its all-time high of -$6.83 million, reached on June 30, 2022.
Performance
ANEB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.14 M
-$850.70 K-65.93%
September 30, 2024
Summary
- As of February 8, 2025, ANEB quarterly EBITDA is -$2.14 million, with the most recent change of -$850.70 thousand (-65.93%) on September 30, 2024.
- Over the past year, ANEB quarterly EBITDA has dropped by -$547.20 thousand (-34.33%).
- ANEB quarterly EBITDA is now -748.59% below its all-time high of -$252.30 thousand, reached on September 30, 2020.
Performance
ANEB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$7.71 M
+$339.80 K+4.22%
September 30, 2024
Summary
- As of February 8, 2025, ANEB TTM EBITDA is -$7.71 million, with the most recent change of +$339.80 thousand (+4.22%) on September 30, 2024.
- Over the past year, ANEB TTM EBITDA has increased by +$1.55 million (+16.69%).
- ANEB TTM EBITDA is now -2956.12% below its all-time high of -$252.30 thousand, reached on September 30, 2020.
Performance
ANEB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ANEB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.4% | -34.3% | +16.7% |
| 3 y3 years | +73.4% | -34.3% | +16.7% |
| 5 y5 years | - | -34.3% | +16.7% |
ANEB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.9% | +73.4% | -99.9% | +44.1% | -12.9% | +77.1% |
| 5 y | 5-year | -17.9% | +73.4% | -748.6% | +92.7% | -2956.1% | +77.1% |
| alltime | all time | -17.9% | +73.4% | -748.6% | +92.7% | -2956.1% | +77.1% |
Anebulo Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.14 M(+65.9%) | -$7.71 M(-4.2%) |
| Jun 2024 | -$8.05 M(-31.4%) | -$1.29 M(-19.0%) | -$8.05 M(-13.0%) |
| Mar 2024 | - | -$1.59 M(-40.7%) | -$9.26 M(-11.5%) |
| Dec 2023 | - | -$2.69 M(+8.3%) | -$10.46 M(-9.8%) |
| Sep 2023 | - | -$2.48 M(-0.6%) | -$11.60 M(-1.1%) |
| Jun 2023 | -$11.73 M | -$2.50 M(-10.8%) | -$11.73 M(+1.5%) |
| Mar 2023 | - | -$2.80 M(-26.9%) | -$11.56 M(+8.6%) |
| Dec 2022 | - | -$3.83 M(+46.5%) | -$10.64 M(+34.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$2.61 M(+12.3%) | -$7.89 M(+15.5%) |
| Jun 2022 | -$6.83 M(-77.4%) | -$2.33 M(+23.7%) | -$6.83 M(-79.7%) |
| Mar 2022 | - | -$1.88 M(+75.5%) | -$33.62 M(+4.1%) |
| Dec 2021 | - | -$1.07 M(-31.1%) | -$32.29 M(+2.4%) |
| Sep 2021 | - | -$1.55 M(-94.7%) | -$31.54 M(+4.3%) |
| Jun 2021 | -$30.24 M | -$29.11 M(+5172.9%) | -$30.24 M(+2578.5%) |
| Mar 2021 | - | -$552.10 K(+70.1%) | -$1.13 M(+95.7%) |
| Dec 2020 | - | -$324.60 K(+28.7%) | -$576.90 K(+128.7%) |
| Sep 2020 | - | -$252.30 K | -$252.30 K |
FAQ
- What is Anebulo Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals annual EBITDA year-on-year change?
- What is Anebulo Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Anebulo Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals TTM EBITDA year-on-year change?
What is Anebulo Pharmaceuticals annual EBITDA?
The current annual EBITDA of ANEB is -$8.05 M
What is the all time high annual EBITDA for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high annual EBITDA is -$6.83 M
What is Anebulo Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ANEB annual EBITDA has changed by +$3.68 M (+31.38%)
What is Anebulo Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of ANEB is -$2.14 M
What is the all time high quarterly EBITDA for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high quarterly EBITDA is -$252.30 K
What is Anebulo Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ANEB quarterly EBITDA has changed by -$547.20 K (-34.33%)
What is Anebulo Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of ANEB is -$7.71 M
What is the all time high TTM EBITDA for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high TTM EBITDA is -$252.30 K
What is Anebulo Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ANEB TTM EBITDA has changed by +$1.55 M (+16.69%)